| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.08 |